[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Clinical research: an outsourcing opportunity (Analyst Insight)

March 2010 | 12 pages | ID: CC832427178EN
Ovum

US$ 895.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The life sciences industry is facing significant challenges, many of which are unique to the sector. At the same time, the market as a whole is becoming more open to outsourcing, having begun to shake off the conservatism that dogged it in the first half of the last decade. Consequently, there are increasing opportunities for outsourcing vendors to make their mark in this potentially highly lucrative industry. Here we provide an overview of the issues facing the pharmaceuticals (pharma) and biotechnology (biotech) sectors and highlight a key outsourcing opportunity around the delivery of services related to the clinical research and development process.
SUMMARY

Impact
Ovum view
Key messages

PHARMA AND BIOTECH HAVE BEGUN TO EMBRACE OUTSOURCING

Pharma is facing significant challenges
R&D costs are a major issue for pharma companies

OUTSOURCING CLINICAL TRIALS CAN SIGNIFICANTLY REDUCE COSTS

The market for CROs
CROs: part of the KPO landscape?

OUTSOURCING GIANTS ARE ESTABLISHING THEMSELVES IN THE PHARMA MARKET

Expanding service range to include KPO for life sciences clients
Outsourcers are focusing on clinical data management

RECOMMENDATIONS

Avoid direct competition with CROs
Utilize a multi-shore delivery model
Understand the specific concerns of pharma companies
Recognize the importance of strong client relationships

APPENDIX

Further reading
Methodology

LIST OF FIGURES

Figure 1: Value of IT services deals awarded by pharmaceutical companies, 2002–2009
Figure 2: An in-depth look at the clinical trials process


More Publications